www.cpexpharm.com
HOME
COMPANY PROFILE
MANAGEMENT
INVESTOR RELATIONS
OVERVIEW
CORPORATE GOVERNANCE
STOCK TRANSFER AGENT
SEC FILINGS
SECTION 16 FORMS
PRESENTATIONS/EVENTS
PUBLICATIONS
 PRESS RELEASES
ANNUAL REPORTS
CONTACT

 
 
  To view our documents, you must use software that is capable of opening PDF (portable document format) files. Our documents are compatible with Adobe® v6.0 and higher.
Get Acrobat Reader
 

[ 2010 | 2009 | 2008 ]

FEBRUARY 01, 2010
CPEX PHARMACEUTICALS ANNOUNCES APPOINTMENT OF NEW CHIEF SCIENTIFIC OFFICER

JANUARY 08, 2010
CPEX PHARMACEUTICALS REPORTS ON SEC FILING BY ARCADIA CAPITAL ADVISORS

If you are interested in receiving an investor packet, please call us at 603.658.6100.

 
 
 
FEBRUARY 01, 2010
CPEX PHARMACEUTICALS ANNOUNCES APPOINTMENT OF NEW CHIEF SCIENTIFIC OFFICER
 
JANUARY 08, 2010
CPEX PHARMACEUTICALS REPORTS ON SEC FILING BY ARCADIA CAPITAL ADVISORS
 
DECEMBER 21, 2009
CPEX PHARMACEUTICALS ANNOUNCES COMPLETION OF ENROLLMENT IN PHASE 2A CLINICAL TRIAL OF NASULIN™
 

P I P E L I N E
 
P A R T N E R I N G
 
F A C T   S H E E T
 
 
[ HOME | COMPANY PROFILE | MANAGEMENT | INVESTOR RELATIONS | CONTACT ]
 
CPEX PHARMACEUTICALS, INC.
2 HOLLAND WAY
EXETER NH 03833

TEL: 603.658.6100
FAX: 603.658.6101